SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-092358
Filing Date
2015-03-16
Accepted
2015-03-16 08:03:05
Documents
3
Period of Report
2015-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d885257d8k.htm 8-K 18356
2 EX-5.1 d885257dex51.htm EX-5.1 5014
3 EX-10.1 d885257dex101.htm EX-10.1 193552
  Complete submission text file 0001193125-15-092358.txt   218043
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34637 | Film No.: 15701135
SIC: 2834 Pharmaceutical Preparations